Clinical trial
Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal…
NCT00133211 · Danish Heart Foundation, Other · Completed
Key facts
| NCT number | NCT00133211 |
|---|---|
| Title | Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation |
| Official title | Medical Antiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: A Randomized Prospective Multicentre Study (MANTRA-PAF) |
| Acronym | MANTRA-PAF |
| Lead sponsor | Danish Heart Foundation, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Procedure |
| Interventions | Radiofrequency ablation |
| Enrollment | 294 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2014 |
| Completion | Sep 1, 2014 |
| First posted | Aug 23, 2005 |
| Last update posted | Mar 6, 2015 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: